Epithelial splicing regulatory proteins 1 (ESRP1) and 2 (ESRP2) suppress cancer cell motility via different mechanisms

Journal of Biological Chemistry

Volumn 289, Issue 40, 2014, Pages 27386-27399

  Ishii, Hiroki ^a   Saitoh, Masao ^a   Sakamoto, Kei ^b   Kondo, Tetsuo ^a   Katoh, Ryohei ^a   Tanaka, Shota ^a   Motizuki, Mitsuyoshi ^a   Masuyama, Keisuke ^a   Miyazawa, Keiji ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION; CELL CULTURE; DISEASES; PATHOLOGY; PROTEINS;

ACTIN CYTOSKELETON; ALTERNATIVE SPLICING; CARCINOMA CELL LINES; CELL-CELL ADHESION; DIFFERENT MECHANISMS; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; REGULATORY PROTEIN;

CELLS;

EPITHELIAL SPLICING REGULATORY PROTEIN 1; EPITHELIAL SPLICING REGULATORY PROTEIN 2; GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN DELTA EF1; PROTEIN RAC1B; PROTEIN SIP1; REGULATOR PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; UVOMORULIN; ESRP1 PROTEIN, HUMAN; ESRP2 PROTEIN, HUMAN; RNA BINDING PROTEIN;

ACTIN FILAMENT; ARTICLE; CANCER CELL; CARCINOGENESIS; CELL ADHESION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE SILENCING; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; METASTASIS; MOUTH SQUAMOUS CELL CARCINOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; RNA SPLICING; TUMOR INVASION; UPREGULATION; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOPLASM; PATHOPHYSIOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL MOVEMENT; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; RNA-BINDING PROTEINS;

EID: 84907483753     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.589432     Document Type: Article

References (44)

1. Arnoux, V., Nassour, M., L'helgoualc'h, A., Hipskind, R.A., and Savagner, P. (2008) Erk5 controls slug expression and keratinocyte activation during wound healing.Mol. Biol. Cell19, 4738-4749
2. Zeisberg, E. M., Tarnavski, O., Zeisberg, M., Dorfman, A. L., McMullen, J. R., Gustafsson, E., Chandraker, A., Yuan, X., Pu, W. T., Roberts, A. B., Neilson, E. G., Sayegh, M. H., Izumo, S., and Kalluri, R. (2007) Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat. Med. 13, 952-961
3. Polyak, K., and Weinberg, R. A. (2009) Transitions between epithelial and mesenchymal states: Acquisition of malignant and stem cell traits. Nat. Rev. Cancer 9, 265-273
4. Thiery, J. P., Acloque, H., Huang, R. Y., and Nieto, M. A. (2009) Epithelial to mesenchymal transitions in development and disease. Cell 139, 871-890
5. De Craene, B., and Berx, G. (2013) Regulatory networks defining EMT during cancer initiation and progression. Nat. Rev. Cancer 13, 97-110
6. Bracken, C. P., Gregory, P. A., Kolesnikoff, N., Bert, A. G., Wang, J., Shannon, M. F., and Goodall, G. J. (2008) A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelialmesenchymal transition. Cancer Res. 68, 7846-7854
7. Bindels, S., Mestdagt, M., Vandewalle, C., Jacobs, N., Volders, L., Noël, A., van Roy, F., Berx, G., Foidart, J. M., and Gilles, C. (2006) Regulation of vimentin by SIP1 in human epithelial breast tumor cells. Oncogene 25, 4975-4985
8. Shapiro, I. M., Cheng, A. W., Flytzanis, N. C., Balsamo, M., Condeelis, J. S., Oktay, M. H., Burge, C. B., and Gertler, F. B. (2011) An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype. PLoS Genet. 7, e1002218
9. Horiguchi, K., Sakamoto, K., Koinuma, D., Semba, K., Inoue, A., Inoue, S., Fujii, H., Yamaguchi A., Miyazawa, K., Miyazono, K., and Saitoh, M. (2012) TGF-β drives epithelial-mesenchymal transition through ΔEF1medicated downregulation of ESRP. Oncogene 31, 3190-3201
10. Warzecha, C. C., Jiang, P., Amirikian, K., Dittmar, K. A., Lu, H., Shen, S., Guo, W., Xing, Y., and Carstens, R. P. (2010) An ESRP-regulated splicing programme is abrogated during the endothelial-mesenchymal transition. EMBO J. 29, 3286-3300
11. Shiraldhara, T., Horiguchi, K., Miyazawa, K., Ehata, S., Shibata, T., Morita, I., Miyazono, K., and Saitoh, M. (2011) TGF-β regulates isoform switching of FGF receptors and epithelial-mesenchymal transition. EMBO J. 30, 783-795
12. Shiraldhara, T., Kawasaki, T., Fukagawa, A., Semba, K., Sakai, R., Miyazono, K., Miyazawa, K., and Saitoh, M. (2013) Identification of integrin α3 as a molecular marker of cells undergoing epithelial-mesenchymal transition and of cancer cells with aggressive phenotypes. Cancer Sci. 104, 1189-1197
13. Leontieva, O. V., and Ionov, Y. (2009) RNA-binding motif protein 35 A is a novel tumor suppressor for colorectal cancer. Cell Cycle 8, 490-497
14. Yae, T., Tsuchihashi, K., Ishimoto, T., Motohara, T., Yoshikawa, M., Yoshida, G. J., Wada, T., Masulco, T., Mogushi, K., Tanaka, H., Osawa, T., Kanki, Y., Minami, T., Aburatani, H., Ohmura, M., Kubo, A., Suematsu, M., Takahashi, K., Saya, H., and Nagano, O. (2012) Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell. Nat. Commun. 3, 883
15. Warzecha, C. C., Shen, S., Xing, Y., and Carstens, R. P. (2009) The epithelial splicing factors ESRP1 and ESRP2 positively and negatively regulate diverse types of alternative splicing event. RNA Biol. 6, 546 -562
16. Di Modugno, F., Iapicca, P., Boudreau, A., Mottolese, M., Terrenato, I., Perracchio, L., Carstens, R. P., Santoni, A., Bisseil, M. J., and Nisticò, P. (2012) Splicing program of human MENA produces a previously undescribed isoform associated with invasive, mesenchymal-like breast tumors. Proc. Natl. Acad. Sci. U.S.A. 109, 19280-19285
17. Lu, H., Liu, J., Liu, S., Zeng, J., Ding, D., Carstens, R. P., Cong, Y., Xu, X., and Guo, W. (2013) Exo70 isoform switching upon epithelial-mesenchymal transition mediates cancer cell invasion. Dev. Cell 27, 560 -573
18. Chikamatsu, K., Sakakura, K., Yamamoto, T., Furuya, N., Whiteside, T. L., and Masuyama, K. (2008) CD4+ T helper responses in squamous cell carcinoma of the head and neck. Oral Oncol. 44, 870 - 877
19. Ikushima, H., Komuro, A., Isogaya, K., Shinozaki, M., Heilman, U., Miyazawa, K., and Miyazono, K. (2008) An Id-like molecule, HHM, is a synexpression group-restricted regulator of TGF-β signaling. EMBO J. 27, 2955-2965
20. Motizuki, M., Isogaya, K., Miyake, K., Ikushima, H., Kubota, T., Miyazono, K., Saitoh, M., and Miyazawa, K. (2013) Oligodendrocyte transcription factor 1 (Olig1) is a Smad cofactor involved in cell motility induced by transforming growth factor-β. J. Biol. Chem. 288, 18911-18922
21. Ishii, H., Chikamatsu, K., Sakakura, K., Miyata, M., Furuya, N., and Masuyama, K. (2010) Primary tumor induces sentinel lymph node lymphangiogenesis in oral squamous cell carcinoma. Oral Oncol. 46, 373-378
22. Brown, R. L., Reinlce, L. M., Damerow, M. S., Perez, D., Chodosh, L. A., Yang, J., and Cheng, C. (2011) CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression. J. Clin. Invest. 121, 1064-1074
23. Gonçalves, V., Matos, P., and Jordan, P. (2009) Antagonistic SR proteins regulate alternative splicing of tumor-related Raclb downstream of the PI3-kinase and Wnt pathways. Hum. Mol. Genet. 18, 3696 -3707
24. Fiegen, D., Haeusler, L. C., Blumenstein, L., Herbrand, U., Dvorsky, R., Vetter, I. R., and Ahmadian, M. R. (2004) Alternative splicing of Rac1 generates Rac1b, a self-activating GTPase. J. Biol. Chem. 279, 4743-4749
25. Radisky, D. C., Levy, D. D., Littlepage, L. E., Liu, H., Nelson, C. M., Fata, J. E., Leake, D., Godden, E. L., Albertson, D. G., Nieto, M. A., Werb, Z., and Bisseil, M. J. (2005) Raclb and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 436, 123-127
26. Warzecha, C. C., Sato, T. K., Nabet, B., Hogenesch, J. B., and Carstens, R. (2009) ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing. Mol. Cell 33, 591-601
27. Ueda, J., Matsuda, Y., Yamahatsu, K., Uchida, E., Naito, Z., Kore, M., and Iwashita, T. (2013) Epithelial splicing regulatory protein 1 is a favorable prognostic factor in pancreatic cancer that attenuates pancreatic metastases. Oncogene DOI 10.1038/onc.2013.392
28. Revil, T., and Jerome-Majewska, L. A. (2013) During embryogenesis, Esrpl expression is restricted to a subset of epithelial cells and is associated with splicing of a number of developmentally important genes. Dev. Dyn. 242, 281-290
29. Warzecha, C. C., and Carstens, R. P. (2012) Complex changes in alternative pre-mRNA splicing play a central role in the epithelial-to-mesenchymal transition (EMT). Semin. Cancer Biol. 22, 417-427
30. Fagoonee, S., Bearzi, C., Di Cunto, F., Clohessy, J. G., Rizzi, R., Reschke, M., Tolosano, E., Provero, P., Pandolfi, P. P., Silengo, L., and Altruda, F. (2013) The RNA binding protein ESRP1 fine-tunes the expression of pluripotency-related factors in mouse embryonic stem cells. PLoS ONE 8, e72300
31. Comijn, J., Berx, G., Vermassen, P., Verschueren, K., van Grunsven, L., and Bruyneel, E. (2001) The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol. Cell 7, 1267-1278
32. Vandewalle, C., Comijn, J., De Craene, B., Vermassen, P., Bruyneel, E., Andersen, H., Tul chin sky, E., Van Roy, F., and Berx, G. (2005) SIP1/ZEB2 induces EMT byrepressing genes of different epithelial cell-cell junctions. Nucleic Acids Res. 33, 6566-6578
33. Maeda, G., Chiba, T., Okazaki, M., Satoh, T., Taya, Y., Aoba, T., Kato, K., Kawashiri, S., and Imai, K. (2005) Expression of SIP1 in oral squamous cell carcinomas: implications for E-cadherin expression and tumor progression. Int. J. Oncol. 27, 1535-1541
34. Okugawa, Y., Inoue, Y., Tanaka, K., Kawamura, M., Saigusa, S., Toiyama, Y., Ohi, M., Uchida, K., Mohri, Y., and Kusunoki, M. (2013) Smad interacting protein 1 (SIP1) is associated with peritoneal carcinomatosis in intestinal type gastric cancer. Clin. Exp. Metastasis 30, 417-429
35. Peinado, H., Portillo, F., and Cano, A. (2004) Transcriptional regulation of cadherins during development and carcinogenesis. Int. J. Dev. Biol. 48, 365-375
36. Hahn, S., Jackstadt, R., Siemens, H., Hünten, S., and Hermeking, H. (2013) SNAIL and miR-34a feed-forward regulation of ZNF281/ZBP99 promotes epithelial-mesenchymal transition. EMBO J. 32, 3079-3095
37. Melamed, Z., Levy, A., Ashwal-Fluss, R., Lev-Maor, G., Mekahel, K., Atias, N., Gilad, S., Sharan, R., Levy, C., Kadener, S., and Ast, G. (2013) Alternative splicing regulates biogenesis of miRNAs located across exon-intron junctions. Mol. Cell 50, 869 - 881
38. Wu, H., Sun, S., Tu, K., Gao, Y., Xie, B., Krainer, A. R., and Zhu, J. (2010) A splicing-independent function of SF2/ASF in microRNA processing. Mol. Cell 38, 67-77
39. Reinke, L. M., Xu, Y., and Cheng, C. (2012) Snail represses the splicing regulator epithelial splicing regulatory protein 1 to promote epithelialmesenchymal transition. J. Biol. Chem. 287, 36435-36442
40. Gemmill, R. M., Roche, J., Potiron, V. A., Nasarre, P., Mitas, M., Coldren, C. D., Helfrich, B. A., Garrett-Mayer, E., Bunn, P. A., Drabkin, H. A. (2011) ZEB1-responsive genes in non-small cell lung cancer. Cancer Lett. 300, 66-78
41. Xiang, X., Deng, Z., Zhuang, X., Ju, S., Mu, J., Jiang, H., Zhang, L., Yan, J., Miller, D., and Zhang, H. G. (2012) Grhl2 determines the epithelial phenotype of breast cancers and promotes tumor progression. PLoS ONE 7, e50781
42. Jordan, P., Brazåo, R., Boavida, M. G., Gespach, C., and Chastre, E. (1999) Cloning of a novel human Raclb splice variant with increased expression in colorectal tumors. Oncogene 18, 6835-6839
43. Schnelzer, A., Prechtel, D., Knaus, U., Dehne, K., Gerhard, M., Graeff, H., Harbeck, N., Schmitt, M., and Lengyel, E. (2000) Racl in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b. Oncogene 19, 3013-3020
44. Gout, S., Brambilla, E., Boudria, A., Drissi, R., Lantuejoul, S., Gazzeri, S., and Eymin, B. (2012) Abnormal expression of the pre-mRNA splicing regulators SRSF1, SRSF2, SRPK1 and SRPK2 in non-small cell lung carcinoma. PLoS ONE 7, e46539